Opendata, web and dolomites

iNanoBIT SIGNED

Integration of Nano- and Biotechnology for beta-cell and islet Transplantation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iNanoBIT project word cloud

Explore the words cloud of the iNanoBIT project. It provides you a very rough idea of what is the project "iNanoBIT" about.

technological    mr    monitoring    technologies    cells    pancreatic    marketing    imaging    tissue    supply    academic    porcinexenotransplant    beta    regenerative    nano    islet    patients    industrial    proliferation    nanotechnology    competitiveness    missing    ready    nanomolecules    clinical    opening    trials    starting    translation    transplantable    vital    pluripotent    sensitivity    therapies    reinforce    perfect    excellent    models    preclinical    trl    market    scope    safe    arrive    vitro    animal    survival    model    validated    human    develop1    supplies    engraftment    cellular    healthcare    sme    optoacoustic    pet    toolbox    levels    match    stem    function    transplants    provision    sensitive    islets    humans    porcine    types    inanobit    body    vivo    translational    trl6    area    points    cell    molecule    medicinal    nanotechnologies    spect    chain    fast    differentiated    multimodality    subsequent    combination    coordinated    validate   

Project "iNanoBIT" data sheet

The following table provides information about the project.

Coordinator
BIOTALENTUM TUDASFEJLESZTO KFT 

Organization address
address: AULICH LAJOS UTCA 26
city: GOEDOELLO
postcode: 2100
website: www.biotalentum.hu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Hungary [HU]
 Project website http://inanobit.eu/
 Total cost 6˙999˙997 €
 EC max contribution 6˙999˙997 € (100%)
 Programme 1. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-NMBP-2017-two-stage
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2022-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOTALENTUM TUDASFEJLESZTO KFT HU (GOEDOELLO) coordinator 1˙301˙341.00
2    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 1˙629˙575.00
3    Mediso Orvosi Berendezes Fejleszto es Szerviz Kft. HU (BUDAPEST) participant 795˙375.00
4    BBS NANOTECHNOLOGIA KUTATASI ES FEJLESZTESI KORLATOLT FELELOSSEGU TARSASAG HU (DEBRECEN) participant 710˙726.00
5    UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA IT (MILANO) participant 652˙563.00
6    DEFYMED FR (STRASBOURG) participant 645˙625.00
7    ITHERA MEDICAL GMBH DE (MUNCHEN) participant 636˙041.00
8    UNIVERSITE CATHOLIQUE DE LOUVAIN BE (LOUVAIN LA NEUVE) participant 628˙750.00

Map

 Project objective

The iNanoBIT project is aimed to apply nanotechnologies for imaging porcine pancreatic islet cellular transplants and induced pluripotent stem cell-derived beta-cells and subsequent regenerative processes in vivo in a porcine model. The project will develop1) novel highly sensitive nanotechnology-based imaging approaches allowing for monitoring of survival, engraftment, proliferation, function and whole body distribution of the cellular transplants in a preclinical porcine model with excellent translational potential to humans; 2) develop and validate the application of state-of-the-art imaging technologies facilitating the provision of new regenerative therapies to preclinical large animal models and patients; 3) directly contribute to the opening of a new market sector for i) imaging equipment (SPECT, PET/MR, optoacoustic imaging in preclinical large animal models and patients), ii) nano-imaging molecule supplies (nanomolecules allowing multimodality imaging of specific cell types with high sensitivity), iii) validated transplantable in vitro differentiated human beta-cells and porcinexenotransplant islets thus will reinforce the European healthcare supply chain for regenerative medicinal products. The iNanoBIT project will provide the currently missing toolbox for preclinical/clinical testing for a safe translation of regenerative medicinal cellular and tissue products, currently under preclinical and clinical trials, which is vital for the competitiveness of the European healthcare sector in this fast-growing area. The consortium of 5 SME and 3 Academic partners is coordinated and driven by the industrial partners from the field of nanotechnology, imaging and stem cell technologies, providing a perfect match and unique combination addressing the scope and expected impact of the call and providing TRL 3/4 starting points for the key technological elements, and expect to arrive to TRL6 levels of validated technologies ready for marketing by the end of the project.

 Publications

year authors and title journal last update
List of publications.
2018 Elisabeth Kemter, Eckhard Wolf
Recent progress in porcine islet isolation, culture and engraftment strategies for xenotransplantation
published pages: 1, ISSN: 1087-2418, DOI: 10.1097/mot.0000000000000579
Current Opinion in Organ Transplantation 2019-10-30
2018 Elisabeth Kemter, Joachim Denner, Eckhard Wolf
Will Genetic Engineering Carry Xenotransplantation of Pig Islets to the Clinic?
published pages: , ISSN: 1534-4827, DOI: 10.1007/s11892-018-1074-5
Current Diabetes Reports 18/11 2019-10-30
2019 Susanna Sampaolesi, Francesco Nicotra, Laura Russo
Glycans in nanomedicine, impact and perspectives
published pages: 43-60, ISSN: 1756-8919, DOI: 10.4155/fmc-2018-0368
Future Medicinal Chemistry 11/1 2019-10-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INANOBIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INANOBIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.2.)

nTRACK (2017)

Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration

Read More  

iNanoBIT (2017)

Integration of Nano- and Biotechnology for beta-cell and islet Transplantation

Read More  

STARSTEM (2018)

NanoSTARS imaging for STEM cell therapy for arthritic joints

Read More